• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

    1.055 -0.025 (-2.31%)
    Streaming Delayed Price Updated: 1:50 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 145,071
    Open 1.090
    Bid (Size) 1.050 (2,000)
    Ask (Size) 1.060 (300)
    Prev. Close 1.080
    Today's Range 1.030 - 1.100
    52wk Range 0.8127 - 4.190
    Shares Outstanding 5,726,750
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
    King of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical... 
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    King of Prussia, Pennsylvania--(Newsfile Corp. - May 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical... 
    Via Newsfile

    Performance

    YTD
    -3.2%
    -3.2%
    1 Month
    -2.3%
    -2.3%
    3 Month
    -12.1%
    -12.1%
    6 Month
    -1.4%
    -1.4%
    1 Year
    -56.0%
    -56.0%

    More News

    Read More
    News headline image
    Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
    Via Newsfile
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
    Via TheNewswire.com
    News headline image
    Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
    Via NewMediaWire
    News headline image
    Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894
    Via Newsfile
    Topics Initial Public Offering
    Here are the top movers in Wednesday's session. ↗
    Via Chartmill
    Top movers in Wednesday's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
    Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
    What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
    Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
    The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
    What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
    The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.055
    When was Phio Pharmaceuticals Corp. - Common Stock last traded?
    The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 06/18/26 01:50 PM ET
    What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
    The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 6.04M
    How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
    Phio Pharmaceuticals Corp. - Common Stock has 6M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.